Epidemiology of Infections in Pediatric Cancer Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by Rabin Medical Center.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Rabin Medical Center
ClinicalTrials.gov Identifier:
NCT00934115
First received: July 6, 2009
Last updated: July 15, 2009
Last verified: July 2009
  Purpose

Infections are common causes of morbidity and mortality in pediatric cancer patients. Today, there are limited data on the incidence, distribution of specific infections, causative agents and risk factors for severe infections in this population. Moreover, little data exist on the epidemiology of infections among pediatric patients with solid tumors.

The objectives of the present study are to define the incidence, categories of infections by organ systems, etiologic agents and risk factors for infections in different pediatric malignancies. The results of this study will help the investigators to better understand the epidemiology of infections in the different types of pediatric malignancies, enable the investigators to identify high risk patients, and design a better approach to empiric treatment of these patients.

A prospective, multi-center study, conducted in 5 pediatric hematology-oncology units across Israel (Rambam Medical Center, Haemek Medical Center, Schneider Children's Medical Center, Hadassah Medical Center, Soroka Medical Center). All children aged 0-18 years of age, newly diagnosed with cancer and admitted to day care or inpatient departments with fever of >38.0 C will be included in the study. Demographic, clinical and microbiological figures will be collected in each center by a research assistant supervised by the infectious disease specialist. Data will be collected according to a pre-defined Patient Data Form and entered into an electronic data base that will be analyzed accordingly. In each event of febrile episode during chemotherapy, the following data will be collected by a research assistant using a patient data form and computerized software:

  • Demographic data: age, gender, ethnicity.
  • Clinical data: Underlying disease, immunizations, prophylactic antibiotics, presence of central venous catheter, intensity of chemotherapy, duration of fever, duration and severity of neutropenia, diagnosis of present event.
  • Imaging data
  • Microbiological data
  • Outcome

The statistical analysis will be performed by an epidemiologist and statistician using the SPSS 12.0 software.


Condition
Infections

Study Type: Observational
Study Design: Observational Model: Cohort
Official Title: Epidemiology of Infections in Pediatric Cancer Patients: A Prospective Multicenter Study in Israel

Resource links provided by NLM:


Further study details as provided by Rabin Medical Center:

Estimated Enrollment: 200
Study Start Date: January 2008
  Eligibility

Ages Eligible for Study:   up to 20 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Pediatric cancer patients

Criteria

Inclusion Criteria:

  • Pediatric cancer patients admitted to hospital with fever
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Itzhak Levy MD, Schneider Children Medical Center
ClinicalTrials.gov Identifier: NCT00934115     History of Changes
Other Study ID Numbers: 0061-07-RMC
Study First Received: July 6, 2009
Last Updated: July 15, 2009
Health Authority: Israel: Ministry of Health

Keywords provided by Rabin Medical Center:
To define the incidence, categories of infections by organ systems, etiologic agents and risk

ClinicalTrials.gov processed this record on August 19, 2014